MedTrace Logo

Role of Dexamethasone for Erector Spinae Plane Block in Patients Undergoing Total Abdominal Hysterectomy

NCT03769818 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-08-05

No results posted yet for this study

Summary

The aim to study the efficacy of bupivacaine 0.25% with dexamethasone and that of bupivacaine 0.25% alone for erector spinae plane block for postoperative analgesia in patients undergoing total abdominal hysterectomy Group 1: bupivacaine 0.25% + dexamethasone 8 mg

* Group 2: bupivacaine 0.25%
* Group3: control group A prospective Randomized Interventional double-blind study.

Conditions

  • Postoperative Pain

Interventions

DRUG

bupivacaine

Bilateral TAP block with 20 ml of 0.25% bupivacaine

DRUG

dexamethasone

Bilateral TAP block with 4 mg/kg dexamethasone diluted with isotonic saline.

DRUG

placebo to dexamethasone

Bilateral TAP block with placebo to dexamethasone.

DRUG

placebo to bupivacaine

Bilateral TAP block with placebo to bupivacaine.

Sponsors & Collaborators

  • Aswan University Hospital

    lead OTHER

Principal Investigators

  • hany f sallam, md · Aswan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-03-30
Completion
2020-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03769818 on ClinicalTrials.gov